Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -70.09% is 58% above its 5-year average of -168.27%, near the high end of its 5-year range (-404.01%–-26.22%).
78.43% above its 12-month average of -324.97%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -21.42%.
RETURN ON ASSETS (ROA)
-70.09%
RETURN ON ASSETS (ROA) AVG TTM
-324.97%
RETURN ON ASSETS (ROA) AVG 3Y
-229.15%
RETURN ON ASSETS (ROA) AVG 5Y
-168.27%
RETURN ON ASSETS (ROA) AVG 10Y
-140.72%
RETURN ON ASSETS (ROA) AVG 15Y
-132.78%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+78.43%
CURRENT VS 3Y AVG
+69.41%
CURRENT VS 5Y AVG
+58.35%
CURRENT VS 10Y AVG
+50.19%
CURRENT VS 15Y AVG
+47.21%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-117.23%
vs the sector median at left
Immunic, Inc.
Market Cap
$106.52M
Return on Assets (ROA)
-70.09%
TTM Avg
-324.97%
3Y Avg
-229.15%
5Y Avg
-168.27%
Market Cap
$106.93M
Return on Assets (ROA)
-63.19%
TTM Avg
-62.03%
3Y Avg
-51.81%
5Y Avg
-103.22%
Market Cap
$106.96M
Return on Assets (ROA)
-233.43%
TTM Avg
-298.69%
3Y Avg
-252.88%
5Y Avg
-237.20%
Market Cap
$106.98M
Return on Assets (ROA)
-16.87%
TTM Avg
-6.13%
3Y Avg
-6.48%
5Y Avg
-5.59%
Market Cap
$107.09M
Return on Assets (ROA)
-80.25%
TTM Avg
-36.24%
3Y Avg
-78.62%
5Y Avg
-77.58%
Market Cap
$107.17M
Return on Assets (ROA)
-14.14%
TTM Avg
-26.48%
3Y Avg
-30.34%
5Y Avg
-26.58%
Market Cap
$104.68M
Return on Assets (ROA)
-57.98%
TTM Avg
-386.38%
3Y Avg
-312.00%
5Y Avg
-312.00%
Market Cap
$104.26M
Return on Assets (ROA)
-33.85%
TTM Avg
-28.41%
3Y Avg
-17.06%
5Y Avg
-12.28%
Market Cap
$109.14M
Return on Assets (ROA)
-167.64%
TTM Avg
-183.95%
3Y Avg
-119.46%
5Y Avg
-95.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunic, Inc. (IMUX) | $106.52M | -70.09% | -324.97% | -229.15% | -168.27% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | -63.19% | -62.03% | -51.81% | -103.22% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | -233.43% | -298.69% | -252.88% | -237.20% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -16.87% | -6.13% | -6.48% | -5.59% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | -80.25% | -36.24% | -78.62% | -77.58% |
| Apyx Medical Corporation (APYX)vs › | $107.17M | -14.14% | -26.48% | -30.34% | -26.58% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | -57.98% | -386.38% | -312.00% | -312.00% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -33.85% | -28.41% | -17.06% | -12.28% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | -167.64% | -183.95% | -119.46% | -95.34% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | -34.04% | -20.59% | -37.88% | -37.10% |
ROA
-70.1%
ROE
-87.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -404.01% |
| 2024-12-31 | -245.93% |
| 2023-12-31 | -172.40% |
| 2022-12-31 | -94.25% |
| 2021-12-31 | -66.82% |
| 2020-12-31 | -26.22% |
| 2019-12-31 | -52.80% |
| 2018-12-31 | -276.91% |
| 2017-12-31 | -86.24% |
| 2016-12-31 | -63.99% |
| 2015-12-31 | -58.40% |
| 2014-12-31 | -44.10% |
| 2013-12-31 | -70.23% |
| 2012-12-31 | -32.96% |
| 2011-12-31 | -296.47% |
